Eisai
4523.T
#2624
Rank
A$9.73 B
Marketcap
A$34.49
Share price
-1.69%
Change (1 day)
-17.56%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): A$1.31

According to Eisai's latest financial reports the company's current EPS (TTM) is A$1.23. an increase over its 2024 EPS that were of A$1.39.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025A$1.5611.85%
2024A$1.39-32.63%
2023A$2.075.52%
2022A$1.96-74.01%
2021A$7.53-66.58%
2020A$22.5498.24%
2019A$11.3717.01%
2018A$9.7237.78%
2017A$7.05-27.62%
2016A$9.7435.33%
2015A$7.20-2.82%
2014A$7.41-27.66%
2013A$10.24-27.49%
2012A$14.13-12.67%
2011A$16.1888.08%
2010A$8.60-11.06%
2009A$9.67-390.15%
2008A-$3.33-127.78%
2007A$12.0011.78%
2006A$10.744.38%
2005A$10.297.4%
2004A$9.5843.03%
2003A$6.7025.09%
2002A$5.3552.67%
2001A$3.5169.76%
2000A$2.07